Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Colorectal Neoplasms 215Rectal Neoplasms 85Colonic Neoplasms 76Stomach Neoplasms 56Pancreatic Neoplasms 44Neoplasm Metastasis 40Esophageal Neoplasms 37Neoplasms 28Lung Neoplasms 27Carcinoma, Non-Small-Cell Lung 20Small Cell Lung Carcinoma 19Adenocarcinoma Of Esophagus 19Glioblastoma 18Glioma 17Neuroblastoma 16Esophageal Squamous Cell Carcinoma 16Brain Neoplasms 16Breast Neoplasms 15Sarcoma 11Gliosarcoma 10Biliary Tract Neoplasms 10Central Nervous System Neoplasms 9Astrocytoma 8Adenocarcinoma 8Oligodendroglioma 7Medulloblastoma 7Colorectal Cancer Metastatic 7Rhabdomyosarcoma 6Recurrence 6Locally Advanced Rectal Cancer 6

Interventions

Gemcitabine 9Carboplatin 8Paclitaxel 6Capecitabine 4Bevacizumab 4pembrolizumab 3Irinotecan 3Erlotinib Hydrochloride 3atezolizumab 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Filgrastim 2Cisplatin 2CP protocol 2tislelizumab 1tegafur-gimeracil-oteracil 1spartalizumab 1sintilimab 1pertuzumab 1pemigatinib 1olaparib 1ivosidenib 1ipatasertib 1etoposide phosphate 1entrectinib 1cobimetinib 1belinostat 1antineoplaston AS 2-1 1antineoplaston A10 1alectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms, Unknown Primary × Irinotecan × Clear all
NCT00004005 2017-04-26

Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin

St. Jude Children's Research Hospital

Phase 2 Completed
12 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms, Unknown Primary, Rectal Neoplasms, Colorectal Neoplasms

NCT00066781 2017-04-04

Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary

Alliance for Clinical Trials in Oncology

Phase 2 Completed
31 enrolled 8 charts
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00004922 2013-06-19

Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
DermatologicEndocrine

Neoplasms, Unknown Primary, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡